13F HOLDINGS REPORT
Column Group LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0000950123-23-001984
Total Value
$300.4M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | RVMDW | 4,577,840 | $109.0M | 36.30% |
| 2 | NGM Biopharmaceuticals Inc | 62921N105 | 18,136,735 | $91.0M | 30.31% |
| 3 | RAPT Therapeutics Inc | 75382E109 | 2,680,621 | $53.1M | 17.67% |
| 4 | ORIC Pharmaceuticals Inc. | ORIC | 3,568,181 | $21.0M | 7.00% |
| 5 | Tenaya Therapeutics, Inc. | TNYA | 9,400,290 | $18.9M | 6.29% |
| 6 | Surrozen, Inc. | SRZNW | 9,414,795 | $5.5M | 1.82% |
| 7 | eFFECTOR Therapeutics Inc | 28202V108 | 4,309,329 | $1.8M | 0.61% |